Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Innovent Enters into Collaboration with Eli Lilly for Jaypirca®

Monday, December 16, 2024

Innovent Biologics and Eli Lilly and Company have entered into a new agreement for the distribution and promotion of Jaypirca pirtobrutinib in Mainland China

CureGene Secures Clinical Trial Approval for CG-0255 Injection for Innovative Antiplatelet Therapy

Friday, December 13, 2024

CureGene Pharmaceutical has received approval from Chinas National Medical Products Administration NMPA for its Clinical Trial Application CTA for CG Benzenesulfonate for Injection

BeiGene and CSPC Pharmaceutical Enter into Agreement for MAT2A Inhibitor SYH2039

Friday, December 13, 2024

BeiGene has entered into a licensing agreement with CSPC Zhongqi Pharmaceutical The agreement grants BeiGene global rights to SYH a methionine adenosyltransferase A MATA inhibitor under development for treating solid tumours

HUTCHMED Secures Breakthrough Therapy for ORPATHYS® and TAGRISSO® Combination for Lung Cancer Treatment

Thursday, December 12, 2024

HUTCHMED has received Breakthrough Therapy Designation BTD from Chinas National Medical Products Administration NMPA for the combination of ORPATHYS savolitinib and TAGRISSO osimertinib

Everest Medicines Announces the First Prescription of VELSIPITY® Issued in Macau, Officially Beginning to Benefit Asian Patients

Thursday, December 12, 2024

Everest Medicines a biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced that the first prescription of VELSIPITY etrasimod

Pilatus Biosciences Earns FDA Orphan Drug Designation for PLT012

Wednesday, December 11, 2024

Pilatus Biosciences has announced the approval of its leading molecule PLT for the treatment of liver and intrahepatic bile duct cancer HCCICCA PLT is a humanised antiCD antibody with a distinctive dual mechanism of action MOA It simultaneously neutr...

Santhera Pharmaceuticals Announces AGAMREE® Approval for Duchenne Muscular Dystrophy Treatment

Wednesday, December 11, 2024

Santhera Pharmaceuticals has announced that the Chinese National Medical Products Administration NMPA has approved AGAMREE vamorolone for patients aged years and older in China

Nona Biosciences Partners with Kodiak Sciences for Next-Generation Antibody Therapies

Tuesday, December 10, 2024

Nona Biosciences has announced a strategic collaboration with Kodiak Sciences to advance the discovery of innovative multitarget antibodies for treating ophthalmic diseases

Daiichi Sankyo and AstraZeneca Secure Approval for Datopotamab Deruxtecan in Advanced EGFR-Mutated NSCLC

Tuesday, December 10, 2024

Daiichi Sankyo has secured approval for Datopotamab Deruxtecan DatoDXd for treating adult patients with locally advanced or metastatic epidermal growth factor receptormutated EGFRmutated nonsmall cell lung cancer NSCLC

Seres Therapeutics Receives Breakthrough Therapy Designation for SER-155

Tuesday, December 10, 2024

Seres Therapeutics has announced the regulatory approval of SER a treatment aimed at reducing bloodstream infections BSIs in adults undergoing allogeneic haematopoietic stem cell transplant alloHSCT as part of their therapy for haematological maligna...